STAGE-BASED THERAPEUTIC APPROACHES TO BLADDER LEUKOPLAKIA: CLINICAL OUTCOMES
Article Sidebar
Main Article Content
Abstract
Treatment of bladder leukoplakia at various stages presents significant challenges [4, 7, 10, 11, 12, 14]. According to domestic and international literature, both conservative and surgical methods are used in the management of bladder leukoplakia. When choosing a treatment method, it is necessary to consider the patient’s age, the severity of clinical manifestations, and the stage of the disease [1, 5, 8, 16].
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1.Morgan R. Vesical leukoplakia// Br J. Urology. -2010. - vol. 52. -P. 96-100.
2.Mostofi F. Epithelial abnormalities of urinary bladder// Prog Clin Biol Res. 2014. - vol. 162 A. -P. 81-93.
3.Mueller S. Urothelial leukoplakia: new aspects of etiology and therapy// J. Urology. - 2012. - vol. 137. - P. 979-983.
4.Sadikova D.I. Integrative analysis of urinary retention disorders based on literature data// JournalNX. Vol.11, Issue 11, 2025, 27-31
5.Sadikova D.I. Analitycal review of the literature of the diagnosis and treatment of stress urinary incontenence// Web of scientist: International Scientific Research Journal. Vol.6, Issue 12, 2025, 9-14
6.Sadikova D.I. Ontogenetic commonality of the urinary and reproductive systems in women// JournalNX. Vol.11, Issue 12, 2025, 6-9
7.Sadikova D.I. Comprehensive literature review on the diagnosis and management of stress urinary incontenence”// IBMSR, Vol.5, Issue 11, 2025, 199-202
8.Reece R. Leukoplakia of the urinary tract: a review// J. Urology. -2012. -vol. 114. -P. 165-171.
9.Roerborn C.G. Progression of leukoplakia of the bladder to squamous cell carcinoma 19 years after complete urinary diversion// J. Urology. - 2016. - Vol. 140 (3). - P. 603-604.
10.Steven P. Leukoplakia of the Bladder// Infections in Urology. -2015. -Vol. 16 (4). -P. 95-102.
11.Walling D. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir// The Journal of infectious diseases. -2016. -Vol. 188 (6). -P. 883-890.
12.Walling D. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia//The Journal of infectious diseases. -2014. -Vol. 190 (2). -P.396-399.
13.Бочарова О.А. Роль адгезивных нарушений в патогенезе лейкоплакии и возможности их коррекции иммуномодулятором//Иммунология. — 2014. -Т 25, № 1. -С. 36-43.
14.Клименко И.А. Цитологическое исследование в диагностике и диспансерном наблюдении больных с предопухолевыми заболеваниями мочевого пузыря //Лабораторное дело. -2013. -№ 9. -С. 544-547.
15.Курбатов Д.Г. Трансуретральная электрорезекция и электровапоризация в диагностике и лечении лейкоплакии мочевого пузыря// Материалы Всерос. научно-практ. конф. -Новокузнецк, 2015. С. 177-178.
16.Романенко А.М. Лейкоплакия мочевого пузыря//Архив патологии. -2015. -№ 1. -С. 39-42.
17.Шабад А.Л. Клинико-биохимические особенности лейкоплакии мочевого пузыря // Вопросы онкологии. -2013. -№ 2. -С. 61-64.